Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215033
Status:
TERMINATED
Last Update Posted:
2012-03-16
First Post:
2005-09-20
Brief Title:
Relationship Between EBV and PTLD
Sponsor:
Childrens Healthcare of Atlanta
Organization:
Childrens Healthcare of Atlanta
Study Overview
Official Title:
Relationship Between Quantitative Epstein-Bar ViralEBV Titres and Post-Transplant Lymphoproliferative Disease
Status:
TERMINATED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
sufficient data gathered to support conclusion
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD
Detailed Description:
The relationship between Epstein-Barr virus and lymphoproliferative disease has been established particularly in the immuno-suppressed patient Over the past several years a quantitative EBV PCR lab test has been established Unfortunately the significance of an elevated test remains unclear The relationship of a particular EBV PCR value and the risk of developing PTLD is unknown The primary aims will be to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD The study will be conducted through a retrospective chart review of approximately 160 patients and we will look at postoperative data including Quantitative EBV PCR results the presence absence of PTLD and the treatment of PTLD and results of EBV PCR with treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None